ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

11 hedge funds and large institutions have $404K invested in Enlivex Therapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$30.7K
2
BlackRock
BlackRock
New York
+$17K
3
Citadel Advisors
Citadel Advisors
Florida
+$17K
4
FPF
FNY Partners Fund
New York
+$13K
5
WS
Wedbush Securities
California
+$11K

Top Sellers

1
SM
Sabby Management
Florida
-$334K
2
AFM
Anson Funds Management
Texas
-$282K
3
KCM
Knoll Capital Management
Florida
-$214K
4
OC
Oppenheimer & Co
New York
-$7.99K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$167K -$334K -11,006 -67%
Renaissance Technologies
2
Renaissance Technologies
New York
$121K +$30.7K +1,010 +34%
VKH
3
Virtu KCG Holdings
New York
$20K +$8.84K +298 +79%
HighTower Advisors
4
HighTower Advisors
Illinois
$19K – – –
BlackRock
5
BlackRock
New York
$17K +$17K +562 New
Citadel Advisors
6
Citadel Advisors
Florida
$17K +$17K +570 New
FPF
7
FNY Partners Fund
New York
$13K +$13K +450 New
OC
8
Oppenheimer & Co
New York
$11K -$7.99K -260 -42%
WS
9
Wedbush Securities
California
$11K +$11K +375 New
UBS Group
10
UBS Group
Switzerland
$7K +$3.9K +128 +125%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$1K – – –
AFM
12
Anson Funds Management
Texas
– -$282K -6,770 Closed
KCM
13
Knoll Capital Management
Florida
– -$214K -5,151 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$1K -13 Closed